Home › Myotonic Dystrophy › California
Myotonic Dystrophy clinical trials in California
5 studies for Myotonic Dystrophy are looking for participants at sites in California.
Cities in California
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
- UCSD - Altman Clinical and Translational Research Institute, La Jolla
- UCLA Medical Center (Department of Neurology), Los Angeles
- Stanford Neuroscience Health Center, Palo Alto
RecruitingPhase 3
Ages 16 and older · All sexes · Updated Sep 25, 2026 · NCT07486934DMCRN-02-001: Assessing Pediatric Endpoints in DM1
- University of California, Los Angeles, Los Angeles
RecruitingObservational study
59 Months · All sexes · Updated Jun 10, 2026 · NCT05224778Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
- University of California, San Diego, La Jolla
- University of California, Los Angeles, Los Angeles
RecruitingObservational study
Ages 18 to 70 · All sexes · Updated Jun 10, 2026 · NCT03981575Study of ATX-01 in Participants With DM1
- UCLA, Los Angeles
RecruitingPhase 1/2
Ages 18 to 64 · All sexes · Updated Feb 10, 2026 · NCT06300307Myotonic Dystrophy Family Registry
- Myotonic Dystrophy Foundation, Oakland
RecruitingObservational study
All ages · All sexes · Updated Nov 21, 2024 · NCT02398786From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.